{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-004148","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.926353+00:00","generated_at":"2026-06-19T02:44:20.479093+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Two co-founders to retire from Treace Medical board; director reclassified","bullets":["F. Barry Bays and Thomas Timbie will retire from the Board at the 2023 annual meeting and not stand for re-election.","Both have served since the company's founding in June 2014; retirements not due to any disagreement.","Director Jane E. Kiernan reclassified as Class II director effective immediately before the 2023 annual meeting.","Kiernan will stand for election as a Class II director at the 2023 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-004148","json":"https://secwatch.observer/filing/0000950170-23-004148.json","markdown":"https://secwatch.observer/filing/0000950170-23-004148.md","text":"https://secwatch.observer/filing/0000950170-23-004148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/tmci-20230216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T02:44:20.479093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"131c8ab979","claim":"Thomas Timbie departed as Director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cb7a82be11","claim":"F. Barry Bays departed as Director at TREACE MEDICAL CONCEPTS, INC..","evidence_excerpt":"On February 16, 2023, F. Barry Bays and Thomas Timbie provided notice to the board of directors (the “ Board ”) of Treace Medical Concepts, Inc. (the “ Company ”) of their intent to retire from the Board at the expiration of their current terms at the 2023 annual meeting of stockholders (the “ 2023 Annual Meeting ”) and not to stand for re-election.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000095017023004148/0000950170-23-004148-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}